 Predictive Oncology Inc. NASDAQ:POAI is beefing up its board with the appointment of David Smith, a life sciences and corporate attorney, veteran biotech industry executive and leading authority on the legal issues surrounding the therapeutic use of human tissue and cells. In a statement, the Minnesota-based biotech company cited Smiths extensive transactional experience, venture financings and regulatory matters for life sciences companies and investors. 